PF-Atlas › Clinical Trials › NCT01748084

Rituximab in Systemic Sclerosis

Rituximab · Phase 2

Registry ID
NCT01748084
Phase
Phase 2
Status
Completed
Drug / intervention
Rituximab
Sponsor
Assistance Publique - Hôpitaux de Paris
Start
2013-04-09
Enrollment
22
Locations
1

About this trial

The purpose of this study is to determine whether rituximab is effective in the treatment of articular symptoms that occur in systemic sclerosis related polyarthritis

View NCT01748084 on ClinicalTrials.gov →

Explore related

All Rituximab trialsAll IPF trials

Related trials

Rituximab — NCT01086540Rituximab — NCT01862926Rituximab — NCT02990286Rituximab — NCT05596786Rituximab — NCT03069248Rituximab — NCT01969409
Medical disclaimer. This page summarizes public trial data for NCT01748084 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.